DRUG INDUSTRY

Addresses

Award Presentation to Hoffmann-Laroche, Inc.: Ronald Kuntzman, 13866 [28MY]

Advertisements

Senior Citizens—Call Senator Exon Today or Get Stuck With the Bill Tomorrow: Pharmaceutical Manufacturers Association, 26129 [1OC]

Articles and editorials

Case of Honorable Drug Dumping, 33552 [1DE]

Cholinergic Drugs in Alzheimer's Disease, 8801 [9AP]

Miracle Company—Excellence in the Lab and Executive Suite Makes Merck a Powerhouse, 28439-28441 [20OC]

Southern Research Likely To Be in Front Ranks When Drugs To Fight AIDS Found, 3708 [19FE]

Team of World Champions, 32690 [18NO]

UAB Discovery Adds Life, Hope to Leukemia Victims, 2771 [4FE]

Bills and resolutions

Controlled Substances Act: designate anabolic steroid methandrosterolone a Schedule I controlled substance (see H.R. 3216)

Dept. of HHS: regulating food as drugs (see H.R. 633)

Diethyl-stilbestrol: funds for programs to identify and aid individuals exposed to (see H.R. 164)

Drugs: ban reimportation, restrict samples, and ban resales by hospitals (see S. 368)

———ban reimportation of those produced in the U.S., restrict distribution of samples, and ban certain resales by hospitals and other medical facilities (see H.R. 1207)

———limit dispensing by practitioners (see H.R. 2093)

———orphan drugs (see H.R. 3349)

Foreign trade: ban certain imported drugs (see H.R. 1031)

———suspend duties on certain drugs (see S. 1900)

Laetrile: exemption from Federal Food, Drug, and Cosmetic Act (see H.R. 651)

Narcotics: international control policy (see S. 15)

National DES Awareness Week: designate (see S.J. Res. 17)

Physicians: limit dispensing of drugs (see H.R. 2093)

Tariff: antibiotic intermediates (see S. 1496, 1497)

Hearings

Committee on Appropriations (Senate): CFTC and FDA budgets (testimony), D216 [1AP]

Committee on Government Operations: FDA regulation of experimental drugs (testimony), D297 [29AP]

Meetings

Committee on Energy and Commerce: Prescription Drug Marketing Act (H.R. 1207), D248 [8AP]

Remarks in House

CIBA Geigy Pharmaceuticals Co.: tribute, 14097 [28MY]

Drugs: orphan drugs (H.R. 3349), 25672 [29SE]

Federal Food, Drug, and Cosmetic Act: amend to limit the dispensation of certain drugs (H.R. 2168), 18403 [30JN]

G.D. Searle & Co.: tribute, 26234 [1OC]

Merck & Co.: eliminating river blindness, 30260 [29OC]

Physicians: limit dispensing of drugs (H.R. 2093), 8919 [9AP]

Prescription Drug Marketing Act: enact (H.R. 1207), 10960-10964 [4MY], 15394 [10JN]

Terminally illl: deregulation of certain drugs, 5551 [12MR]

Remarks in Senate

Advertising: prescription drug benefits, 26129 [1OC]

Alzheimer's disease: clinical trials on use of certain drugs (S. 997), 8800 [9AP]

Cancer: use of parenteral diacetylmorphine (S. 143), 583 [6JA]

Compassionate Pain Relief Act: enact (S. 143), 583 [6JA]

Diseases: treatment of river blindness with new drug called Mectizan, 33660 [2DE], 34249 [4DE]

Drugs: ban reimportation, restrict drug samples, and ban certain resales by hospitals (S. 368), 1640-1642 [21JA]

Hoffmann-Laroche, Inc.: tribute, 13866 [28MY]

Medicare: prescription drugs, 31565 [10NO]

Merck & Co., Rahway, NJ: tribute, 28439 [20OC]

Mithramycin: treatment of chronic granulocytic leukemia, 2771 [4FE]

Orphan Drug Act: funding, 13699, 13701, 13704, 13713, 13728 [27MY]

Reports

National Drunk and Drugged Driving Awareness Week: Committee on the Judiciary (S.J. Res. 136), 29882 [29OC]

Pharmaceutical Industry: Library of Congress, 25043 [23SE]

Reports filed

FDA Continues To Permit the Illegal Marketing of Carcinogenic Additives: Committee on Government Operations (H. Rept. 100-361), 27174 [9OC]

FDA Regulations on Merital: (H. Rept. 100-206), 19054 [8JY]

Federal Food, Drug, and Cosmetic Act: Committee on Energy and Commerce (H.R. 1207) (H. Rept. 100-76), 10836 [30AP]

Summaries

Orphan Drug Amendments (H.R. 3349), 25672 [29SE]

Texts of

H.R. 1207, Prescription Drug Marketing Act, 10960-10962 [4MY]

S. 368, ban reimportation of drugs, restrict drug samples, and ban certain resales by hospitals, 1641 [21JA]